Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U; FLEX Study Team..

Lancet. 2009 May 2;373(9674):1525-31. doi: 10.1016/S0140-6736(09)60569-9.

PMID:
19410716
2.

Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.

Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL.

Cochrane Database Syst Rev. 2014 Nov 17;(11):CD009948. doi: 10.1002/14651858.CD009948.pub2. Review.

PMID:
25400254
3.

Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study.

Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, Nishiwaki Y.

Br J Cancer. 2002 Dec 2;87(12):1360-4. Review.

4.

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.

Rossi A, Chiodini P, Sun JM, O'Brien ME, von Plessen C, Barata F, Park K, Popat S, Bergman B, Parente B, Gallo C, Gridelli C, Perrone F, Di Maio M.

Lancet Oncol. 2014 Oct;15(11):1254-62. doi: 10.1016/S1470-2045(14)70402-4. Review.

PMID:
25232001
5.
6.

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck.

Frampton JE.

Drugs. 2010 Oct 22;70(15):1987-2010. doi: 10.2165/11205010-000000000-00000. Review.

PMID:
20883055
7.

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS.

Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Review.

PMID:
19632939
8.

The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials.

Sheng J, Yang YP, Zhao YY, Qin T, Hu ZH, Zhou T, Zhang YX, Hong SD, Ma YX, Zhao HY, Huang Y, Zhang L.

Medicine (Baltimore). 2015 Aug;94(34):e1400. doi: 10.1097/MD.0000000000001400. Review.

9.

Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer.

Bunn PA Jr, Franklin W.

Semin Oncol. 2002 Oct;29(5 Suppl 14):38-44. Review.

PMID:
12422312
10.

Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancer.

Gridelli C, Maione P, Ferrara ML, Rossi A.

Oncologist. 2009 Jun;14(6):601-11. doi: 10.1634/theoncologist.2008-0153. Review.

11.

Integrating epidermal growth factor receptor-targeted therapies into platinum-based chemotherapy regimens for newly diagnosed non-small-cell lung cancer.

Pirker R, Minar W, Filipits M.

Clin Lung Cancer. 2008;9 Suppl 3:S109-15. doi: 10.3816/CLC.2008.s.016. Review.

PMID:
19419924
12.

The role of cetuximab and other epidermal growth factor receptor monoclonal antibodies in the treatment of advanced non-small cell lung cancer.

Rossi A, Bria E, Maione P, Palazzolo G, Falanga M, Gridelli C.

Rev Recent Clin Trials. 2008 Sep;3(3):217-27. Review.

PMID:
18782080
13.

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.

Gilligan D, Nicolson M, Smith I, Groen H, Dalesio O, Goldstraw P, Hatton M, Hopwood P, Manegold C, Schramel F, Smit H, van Meerbeeck J, Nankivell M, Parmar M, Pugh C, Stephens R.

Lancet. 2007 Jun 9;369(9577):1929-37. Review.

PMID:
17544497
14.

Extending outcomes: epidermal growth factor receptor-targeted monoclonal antibodies in non-small-cell lung cancer.

Joy AA, Butts CA.

Clin Lung Cancer. 2009 Mar;10 Suppl 1:S24-9. doi: 10.3816/CLC.2009.s.004. Review.

PMID:
19362943
15.

Cetuximab in non-small-cell lung cancer.

Pirker R, Filipits M.

Transl Lung Cancer Res. 2012 Mar;1(1):54-60. doi: 10.3978/j.issn.2218-6751.11.01. Review.

16.

Targeting the epidermal growth factor receptor in non-small cell lung cancer.

Steins MB, Reinmuth N, Bischoff H, Kindermann M, Thomas M.

Onkologie. 2010;33(12):704-9. doi: 10.1159/000322214. Review.

PMID:
21124044
17.
18.

Medical treatment of non-small-cell lung cancer.

Buter J, Giaccone G.

Ann Oncol. 2005;16 Suppl 2:ii229-32. Review. No abstract available.

PMID:
15958463
19.

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.

Capdevila J, Elez E, Macarulla T, Ramos FJ, Ruiz-Echarri M, Tabernero J.

Cancer Treat Rev. 2009 Jun;35(4):354-63. doi: 10.1016/j.ctrv.2009.02.001. Review.

PMID:
19269105
20.

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer.

Nieder C, Pawinski A, Dalhaug A, Andratschke N.

Radiat Oncol. 2012 Jan 11;7:3. doi: 10.1186/1748-717X-7-3. Review.

Supplemental Content

Support Center